Tags » Chronic Lymphocytic Leukemia

All Systems Are Go: Let the Countdown Begin

We visited with Dr. Kadia, my leukemia doctor, earlier this month. This was the first time we had to discuss the results of the recent CT scan and bone marrow biopsy. 725 more words


FDA Breakthrough Therapy Designation: Fifth Drug Receives FDA Approval

The FDA approves on April 17th, GlaxoSmithKline’s orphan drug Arzerra (Ofatumumab injection for intravenous infusion), the 5th drug to have the coveted Breakthrough Therapy Designation (BTD). 315 more words

FDA Breakthrough Therapy Designation

My Journey

Good afternoon, I want to let all of you who have been reading my blog, that I am doing great. After last doctor visit in March, I do not have to go back until August. 1,534 more words

Chronic Lymphocytic Leukemia

What’s New, Pussycat?

It’s been a while since I wrote a “health” post, mostly because nothing much is happening. When I first decided to write this blog, I expected a flurry of interesting activities. 571 more words


Round 5 - or is that Round 3?

Sam had his latest round of chemo last week. This was his 5th round in the chemo chair, but technically only his 3rd round of full chemo. 666 more words


Pins and Needles

We have been on pins and needles for over a week. Allow me to explain.

Nine days ago, I was in Houston’s MD Anderson for a long day of doctor’s visits and tests (blood tests, a bone marrow biopsy, and a CT scan). 704 more words

FDA Approves Ibrutinib For Patients With Previously Treated Chronic Lymphocytic Leukemia

In February 2014 the U.S. Food and Drug Administration (FDA) approved ibrutinib as a treatment for patients with chronic lymphocytic leukemia (CLL). This approval is a significant advancement for patients with this blood cancer. 127 more words